로고

  • HOME
  • SITEMAP
  • kOREAN
Home > SmartFilm®Technology > Vulteum® (Tadalafil ODF)

CIALIS is the most selling erectile dysfunction (ED) product in Europe market whose size has been more than US$ 1.3Bn
(Source: R&D Focus 2010 1Q MAT). Lilly’s CIALIS was launched in 2002. In 2009, Pfizer’s VIAGRA had 48%, CIALIS 39%,
and Bayer’s LEVITRA 13% shares in the global market. ED is not just a personal issue any more.
It can affect relationships including with the spouse.

SmartFilm® Technology can also improve the quality of life by protecting privacy of the patient. Thus, Vulteum ® will gradually increase its market share along with the growth of the market, and is also differentiated from other generis
since it is based on SmartFilm® Technology which is easy to carry, store and take.

The Company got Market Authorization Approvals (MAAs) of Vulteum® in Korea as ODF from Ministry of Food and Drug Safety (MFDS) with full dosage including 20mg, 10mg and 5mg and launched them in Sep 4th of 2015.